Results 171 to 180 of about 12,322,600 (360)
ABSTRACT Pathogenic variants in KIF1C cause Spastic Paraplegia 58 (SPG58), typically presenting with cerebellar ataxia and spastic paraparesis. We report two unrelated patients with spastic paraparesis, cerebellar ataxia, and tremor. Whole‐exome sequence analysis identified novel homozygous variants in the motor domain of KIF1C (NM_006612.6): c.921G>A (
Akihiko Mitsutake +12 more
wiley +1 more source
The Impact of Environmental Information Disclosure on the Firm Value of Listed Manufacturing Firms: Evidence from China. [PDF]
Yang Y, Wen J, Li Y.
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Global Value Chains Participation and Productivity Gains for North African Firms [PDF]
Davide Del Prete +2 more
openalex
Stock Return Volatility, Firm Real Option Value, and Mergers and Acquisitions Premiums [PDF]
Uyen Trang Nguyen
openalex +1 more source
Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew +11 more
wiley +1 more source
State ownership and abnormal accruals in highly-valued firms: Evidence from China
Leye Li, Gary S. Monroe, Jenny Jing Wang
openalex +2 more sources

